Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7943484 | 0.87 | MTNR1A (0.47) | KMT2AALDH1A1MEN1CA1CA2 | |
| Trifluoroacetic Acid SCHEMBL7943506 | 0.86 | SMN1; SMN2 (0.51) | SMN1; SMN2KMT2AGLAFPR2ALDH1A1 | |
| SCHEMBL11713117 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2KMT2AGLAGAAFPR2 | |
| SCHEMBL6977801 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2KMT2AGLAGAAFPR2 | |
| SCHEMBL7955831 | 0.80 | CYP2D6 (0.50) | KMT2A | |
| Trifluoroacetic Acid SCHEMBL7104230 | 0.79 | SMN1; SMN2 (0.56) | SMN1; SMN2KMT2AGLAGAAFPR2 | |
| SCHEMBL17152386 | 0.78 | SMN1; SMN2 (0.58) | SMN1; SMN2KMT2AGLAFPR2ALDH1A1 | |
| SCHEMBL9221733 | 0.78 | MAPT (0.55) | SMN1; SMN2KMT2AGLAGAAFPR2 | |
| SCHEMBL13073347 | 0.74 | KMT2A (0.63) | SMN1; SMN2KMT2AGAAFPR2ALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL7943480 | 0.74 | KDM4E (0.49) | KMT2AALDH1A1MEN1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6333338-B1 | ANTICOAGULANTS, CARDIOVASCULAR DISORDERS | LABORATOIRE L. LAFON (FR) | 2001-12-25 | — | — | US | disclosed |